Ekf Diagnostics Share News (EKF)

Renalytix AI Raises GBP22.3 Million, Begins Trading On AIM (ALLIPO)

LONDON (Alliance News) - Renalytix AI PLC started trading on London's AIM Tuesday after raising GBP22.3 million though a placing and subscription to EKF Diagnostics Holdings PLC developer of a

EKF Diagnostics Spin-Off Renalytix AI To Raise GBP22 Million In IPO (ALLIPO)

LONDON (Alliance News) - EKF Diagnostics Holdings PLC's spin-off Renalytix AI PLC confirmed Friday it expects to raise GBP22.3 million in its initial public offering.The Cardiff-based a

Renalytix AI Will Submit Two Kidney Disease Products For US Approval

LONDON (Alliance News) - Renalytix AI PLC, a spin-out of EKF Diagnostics Holdings PLC, said Tuesday it intends to submit two artificial intelligence products for review by the US Food & Drug a

EKF Diagnostics Spin-Out Raises GBP21 Million Through Share Issue (ALLISS)

LONDON (Alliance News) - Medical diagnostics company EKF Diagnostics Holdings PLC on Thursday said its spin-out company Renalytix AI PLC has raised a minimum of GBP21 million through equity AI to

EKF Diagnostics Interim Profit Grows As Costs Fall Despite Revenue Dip

LONDON (Alliance News) - Medical devices maker EKF Diagnostics Holdings PLC said Wednesday its interim profit expanded as administrative costs fell, despite revenue dipping.For the six 21%

EKF Diagnostics Looks To Investors For Possible Renalytix Listing (ALLIPO)

LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Friday that it is looking to undertake further market soundings with investors for the potential listing on AIM of its division Renalytix

Gabelli Value Plus Appoints Christopher Mills Non Executive Director

LONDON (Alliance News) - Gabelli Value Plus Trust PLC said Wednesday that it appointed Christopher Mills as non-executive director with immediate effect.Mills founded Harwood Capital in He

Oryx Net Asset Value Rises In Full-Year On Portfolio Performance

LONDON (Alliance News) - Oryx International Growth Fund Ltd said Tuesday it will not pay a dividend for the year despite an increase in net asset value per share in the 12 months ended NAV per 10%

EKF Diagnostics Signs Manufacturing Partnership With Oragenics

LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Thursday it has signed an exclusive agreement with US pharmaceutical company Oragenics Inc to manufacture Oragenics lantibiotic bulk drug

EKF Subsidiary Teams With Mount Sinai To Fight Kidney Disease

LONDON (Alliance News) - EKF Diagnostics Holdings PLC on Thursday said its subsidiary Renalytix AI PLC has secured an exclusive license and collaboration contract with the Icahn School of Medicine

EKF Diagnostics Swings To 2017 Profit After Cost Reductions

LONDON (Alliance News) - EKF Diagnostics Holdings PLC on Wednesday reported "significantly" improved annual revenues, earnings, and cash as a result of its cost firm

EKF Diagnostics flags budget-beating year

(ShareCast News) - Point-of-care business EKF Diagnostics Holdings announced on Monday that trading in the final quarter of the year ended 31 December was "materially better than budget", and that the overall performance for the year will exceed revised market forecasts, which themselves were recent

EKF Diagnostics sees FY revenues, earnings ahead of market views

(ShareCast News) - AIM-listed point-of-care business EKF Diagnostics said on Monday that revenues and adjusted earnings for the year to the end of December are likely to be ahead of current market forecasts. EKF said early trading in the fourth quarter has again been "materially higher" than budg

EKF Diagnostics boosts earnings in first half

(ShareCast News) - Point-of-care business EKF Diagnostics Holdings announced its unaudited interim results for the six months to 30 June on Monday, ahead of market expectations. The AIM-traded firm said it has an installed base of over 90,000 analysers globally and manufactures over 56 million tests

DIRECTOR DEALINGS: EKF Diagnostics Chairman Ups Interest